You need to login...
If you are not registered...
| Subscribe to Krixos Health: | |
|
or call us on: +43 (0)1 27 63 015 or email: subscribe@krixos.com | |
Most viewed
- 1. AstraZeneca and Daiichi's Enhertu shows pCR rate improvement in breast cancer trial
- 2. BioDlink Congratulates Junshi Biosciences on IND Approval of JS212, a Bispecific ADC Therapeutic Candidate
- 3. UTR Therapeutics Inc Announces IND submission to the US FDA for a First-in-Human Clinical Trial of an mRNA destabilizing drug targeting c-MYC driven cancers
- 4. Incidence of several early-onset cancers increased between 2010 and 2019
- 5. Accuray Showcases New Long-Term Data¹ on Benefits of 5 Session Radiotherapy Treatment for Men with Prostate Cancer at ESTRO 2025
- 6. Dr Boreham's Crucible: The strategy is clear for this x-ray imaging house – can it see it through to profitability?
- 7. Health Check: Neuren says more patients are staying the course as US Daybue sales lift
- 8. Thromboembolic Events in Castration-Resistant Prostate Cancer Patients With and Without Cardiovascular Comorbidities Receiving Oral Androgen Receptor Pathway Inhibitors.
- 9. Xilio Therapeutics Announces Pipeline and Business Updates and First Quarter 2025 Financial Results
- 10. Genitourinary Drugs Market Projected to Hit USD 33.37 Billion by 2032, Driven by Rising Cancer Rates and Urinary Disorders Worldwide | SNS Insider
Last updated at 1:02 GMT
Hot News Makers
Health/Pharma Companies
- 41538.06
- 21571.79
- 21206.17
- 15769.64
- 10559.01
- 8927.20
- 6292.64
- 5898.51
- 5824.65
- 5617.41
Drugs, Treatments, Trials
- 5274.59
- 5137.79
- 4387.15
- 4088.18
- 3738.05
- 1643.58
- 1336.71
- 1027.54
- 985.74
- 776.40
Last updated at 0:10 GMT
